study of tablet Gukshur in patients with high blood pressure

Randomized Controlled Clinical Study To Evaluate The Efficacy Of Tablet Gokshura in Stage-1 Hypertension - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/027960

Enrollment

Registered

2020-09-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I159- Secondary hypertension, unspecified

Interventions

Intervention1: Tablet Gokshura: Orally Two tab each 500 mg two times a day after meal with warm water for 30 days Control Intervention1: Tablet Tagara: Orally two tablets 500 mg each twice a day after

Eligibility

Inclusion criteria

Inclusion criteria: newly dianosed patients with mild Hypertension Systolic blood pressure less than 160 mm of Hg Diastolic blood pressure less than 100 mm of Hg

Exclusion criteria

Exclusion criteria: Complicated hypertensive cases with nephropathy heart block coronary heart disease and retinopathy patient with uncontrolled diabetes mellitus accelerated and malignant hypertention pregnent women

Design outcomes

Primary

Measure	Time frame
optimum blood pressureTimepoint: 30 days	—

Secondary

Measure	Time frame
Reduction in blood pressureTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Eknath Ganesh Kulkarni

Ayurved Mahavidyalaya Nashik

ekulkarni6@gmail.com8080079999

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026